IRON
Disc Medicine Inc.
61.70$
-2.7%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
Disc Medicine Inc. (IRON) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -44 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.9 | -7.0 | -6.9 | -8.9 | -15 | -16 | -16 | 19 | -14 | -9.2 | -9.7 | -12 | -35 | -13 | -7.5 | -18 | -34 | -15 | -17 | -28 | -41 | -48 | -48 | -43 | -62 | -44 | -198 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | |
| 0.1 | 0.1 | 0.2 | 0.6 | 1.6 | 2.9 | 1.7 | 1.7 | 0.3 | 0.4 | 0.4 | 0.0 | 1.0 | 1.3 | 1.3 | 1.9 | 4.1 | 4.1 | 4.3 | 4.3 | 6.4 | 8.4 | 9.5 | 10 | 12 | 14 | 45 | |
| – | – | – | – | – | – | – | – | – | – | 6.4 | 1.1 | 1.0 | 1.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.4 | -0.5 | 0.9 | 0.4 | -0.1 | -2.4 | 0.7 | 3.1 | -4.2 | 2.4 | 0.0 | 12 | -14 | 0.3 | 6.2 | 5.2 | -11 | 7.2 | 7.4 | -2.8 | -7.8 | 0.3 | 6.3 | 8.4 | -10 | 1.4 | 6.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.4 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | 0.0 | – | 0.0 | 0.0 | -0.1 | 0.0 | -0.1 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -220 | -71 | -1.4 | -273 | 52 | 50 | -223 | 58 | 22 | -93 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 77 | -76 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 20 | 0.0 | 14 | 0.1 | 195 | -1.6 | -1.3 | -103 | 0.1 | 0.1 | 0.0 | 154 | 77 | 154 | 0.5 | 7.8 | 16 | 173 | 0.4 | 29 | 244 | 0.9 | 12 | 217 | 1.7 | 32 | 262 | |
| 10 | -7.0 | 1.4 | -8.7 | 180 | -18 | -17 | -62 | -14 | -9.1 | -9.7 | 93 | 42 | 141 | -7.1 | -10 | -18 | -62 | -88 | -0.2 | -70 | 4.7 | 13 | -60 | -2.2 | 9.8 | -39 | |
| -9.9 | -7.0 | -7.0 | -8.9 | -15 | -16 | -16 | 19 | -14 | -9.2 | -9.7 | -13 | -35 | -13 | -7.5 | -18 | -34 | -15 | -17 | -28 | -42 | -48 | -48 | -43 | -62 | -44 | -198 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.